164 related articles for article (PubMed ID: 12808089)
1. Silencing of mouse Aprt is a gradual process in differentiated cells.
Yates PA; Burman R; Simpson J; Ponomoreva ON; Thayer MJ; Turker MS
Mol Cell Biol; 2003 Jul; 23(13):4461-70. PubMed ID: 12808089
[TBL] [Abstract][Full Text] [Related]
2. Aberrantly silenced promoters retain a persistent memory of the silenced state after long-term reactivation.
Oyer JA; Yates PA; Godsey S; Turker MS
Mutat Res; 2011 Jan; 706(1-2):21-7. PubMed ID: 21035468
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation down-regulates CDX1 gene expression in colorectal cancer cell lines.
Suh ER; Ha CS; Rankin EB; Toyota M; Traber PG
J Biol Chem; 2002 Sep; 277(39):35795-800. PubMed ID: 12124393
[TBL] [Abstract][Full Text] [Related]
4. Decreased methylation and transcription repressor Sp3 up-regulated human monoamine oxidase (MAO) B expression during Caco-2 differentiation.
Wong WK; Chen K; Shih JC
J Biol Chem; 2003 Sep; 278(38):36227-35. PubMed ID: 12855685
[TBL] [Abstract][Full Text] [Related]
5. The primary function of a redundant Sp1 binding site in the mouse aprt gene promoter is to block epigenetic gene inactivation.
Mummaneni P; Yates P; Simpson J; Rose J; Turker MS
Nucleic Acids Res; 1998 Nov; 26(22):5163-9. PubMed ID: 9801314
[TBL] [Abstract][Full Text] [Related]
6. Hemidemethylation is sufficient for chromatin relaxation and transcriptional activation of methylated aprt gene in mouse P19 embryonal carcinoma cell line.
Cooper GE; Bishop PL; Turker MS
Somat Cell Mol Genet; 1993 May; 19(3):221-9. PubMed ID: 7687384
[TBL] [Abstract][Full Text] [Related]
7. Evidence that silencing of the HPRT promoter by DNA methylation is mediated by critical CpG sites.
Chen C; Yang MC; Yang TP
J Biol Chem; 2001 Jan; 276(1):320-8. PubMed ID: 11013250
[TBL] [Abstract][Full Text] [Related]
8. Hypermethylation of growth arrest DNA damage-inducible gene 45 beta promoter in human hepatocellular carcinoma.
Qiu W; Zhou B; Zou H; Liu X; Chu PG; Lopez R; Shih J; Chung C; Yen Y
Am J Pathol; 2004 Nov; 165(5):1689-99. PubMed ID: 15509538
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional regulation of mouse delta-opioid receptor gene by CpG methylation: involvement of Sp3 and a methyl-CpG-binding protein, MBD2, in transcriptional repression of mouse delta-opioid receptor gene in Neuro2A cells.
Wang G; Wei LN; Loh HH
J Biol Chem; 2003 Oct; 278(42):40550-6. PubMed ID: 12890683
[TBL] [Abstract][Full Text] [Related]
10. Methylation in the core-promoter region of the chondromodulin-I gene determines the cell-specific expression by regulating the binding of transcriptional activator Sp3.
Aoyama T; Okamoto T; Nagayama S; Nishijo K; Ishibe T; Yasura K; Nakayama T; Nakamura T; Toguchida J
J Biol Chem; 2004 Jul; 279(27):28789-97. PubMed ID: 15107420
[TBL] [Abstract][Full Text] [Related]
11. CpG methylation of promoter region inactivates E-cadherin gene in renal cell carcinoma.
Nojima D; Nakajima K; Li LC; Franks J; Ribeiro-Filho L; Ishii N; Dahiya R
Mol Carcinog; 2001 Sep; 32(1):19-27. PubMed ID: 11568972
[TBL] [Abstract][Full Text] [Related]
12. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
[TBL] [Abstract][Full Text] [Related]
13. Methylation-mediated silencing of TMS1/ASC is accompanied by histone hypoacetylation and CpG island-localized changes in chromatin architecture.
Stimson KM; Vertino PM
J Biol Chem; 2002 Feb; 277(7):4951-8. PubMed ID: 11733524
[TBL] [Abstract][Full Text] [Related]
14. Involvement of epigenetic mechanisms in the regulation of secreted phospholipase A2 expressions in Jurkat leukemia cells.
Menschikowski M; Hagelgans A; Kostka H; Eisenhofer G; Siegert G
Neoplasia; 2008 Nov; 10(11):1195-203. PubMed ID: 18953428
[TBL] [Abstract][Full Text] [Related]
15. Methylation of mouse adenine phosphoribosyltransferase gene is altered upon cellular differentiation and loss of phenotypic expression.
Turker MS
Somat Cell Mol Genet; 1990 Jul; 16(4):331-40. PubMed ID: 1699289
[TBL] [Abstract][Full Text] [Related]
16. Methylation of specific CpG sites in the promoter region could significantly down-regulate p16(INK4a) expression in gastric adenocarcinoma.
Song SH; Jong HS; Choi HH; Kang SH; Ryu MH; Kim NK; Kim WH; Bang YJ
Int J Cancer; 2000 Jul; 87(2):236-40. PubMed ID: 10861481
[TBL] [Abstract][Full Text] [Related]
17. Mapping of the methylation pattern of the MUC2 promoter in pancreatic cancer cell lines, using bisulfite genomic sequencing.
Hamada T; Goto M; Tsutsumida H; Nomoto M; Higashi M; Sugai T; Nakamura S; Yonezawa S
Cancer Lett; 2005 Sep; 227(2):175-84. PubMed ID: 16112420
[TBL] [Abstract][Full Text] [Related]
18. Increased sensitivity of transforming growth factor (TGF) beta 1 null cells to alkylating agents reveals a novel link between TGFbeta signaling and O(6)-methylguanine methyltransferase promoter hypermethylation.
Yamada H; Vijayachandra K; Penner C; Glick A
J Biol Chem; 2001 Jun; 276(22):19052-8. PubMed ID: 11262404
[TBL] [Abstract][Full Text] [Related]
19. Hypermethylation of the p16 (Ink4a) promoter in B6C3F1 mouse primary lung adenocarcinomas and mouse lung cell lines.
Patel AC; Anna CH; Foley JF; Stockton PS; Tyson FL; Barrett JC; Devereux TR
Carcinogenesis; 2000 Sep; 21(9):1691-700. PubMed ID: 10964101
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic down-regulation of death-associated protein kinase in lung cancers.
Toyooka S; Toyooka KO; Miyajima K; Reddy JL; Toyota M; Sathyanarayana UG; Padar A; Tockman MS; Lam S; Shivapurkar N; Gazdar AF
Clin Cancer Res; 2003 Aug; 9(8):3034-41. PubMed ID: 12912953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
